Navigation Links
American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company
Date:11/30/2009

DEL MAR, Calif., Nov. 30 /PRNewswire-FirstCall/ -- American Diversified Holdings Corporation (Pink Sheets: ADHC) is pleased to announce the appointment of Howard M. McEldowney as an independent director to the Company's Board of Directors. Mr. McEldowney, whose investment career spans over a 40 year period starting at the Chemical Bank in New York City and subsequently a founding partner of Harris, Bretall & McEldowney, San Francisco, an institutional money manager and finally a twenty year stint as Chairman, Franklin Templeton Asset Management, the San Mateo, CA based NYSE listed mutual fund manager. Mr. McEldowney, who holds an undergraduate degree and an MBA from Harvard University is currently a private money manager based in Berkeley, CA.

Ernest B. Remo, Chairman/CEO of ADHC says that "the addition of Mr. McEldowney whose broad analysis and investment skills will be invaluable to the future of the Company in evaluating potential acquisitions and ventures in implementing its growth strategy. We are very excited about having a person of Mr. McEldowney's experience on our Board."

About American Diversified Holdings Corporation.

(www.americandiversifiedholdings.com)

American Diversified Holdings Corporation is a publicly traded holding company headquartered in Del Mar, California engaged in developing innovative technologies in the life science sector with the primary emphasis in the stem cell arena. The Enterprise was formed for the express purpose of investing in and acquiring privately held, fast growing companies with established business models that are within a few quarters of profitability. American Diversified Holdings Corporation targets these specific types of companies allowing ADHC to purchase these entities at a significant valuation discount to the public market and then provide the funding necessary for these acquisitions to achieve maximum profit potential using the public equity markets without impairing their balance sheets.

This press release contains forward-looking statements pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. This press release in no way constitutes any recommendation regarding the securities of ADHC or its affiliates. Any person reading this press release is advised that this release should be considered in the light of all facts and circumstances regarding the business and financial condition and prospects of ADHC, and no inference has been made that this release contains all such information.

SOURCE American Diversified Holdings Corporation


'/>"/>
SOURCE American Diversified Holdings Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn
2. American Association for Homecare Endorses New U.S. Senate Bill, the Prevent Health Care Fraud Act of 2009
3. Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs
4. American Diversified Holdings Corporation Announces New Website
5. US Farms, Inc. Receives American Vegetarian Association Certification Approval for Aloe365(TM) Juice Product
6. American Scientific Resources Inc. Issues Corporate Update
7. American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products
8. Holidays Bring Stress, Pains to Many; American Chiropractic Association Offers 12 Days of Health and Wellness for a Healthy, Happy Season
9. Tarkett Sports' Indoor Division Grows as Warthan Associates Join North American Distribution Network
10. American Academy of Cosmetic Surgery Opposes Cosmetic Surgery Tax
11. National Poll Confirms Americans Support Curbs on Malpractice Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... , ... March 30, 2017 , ... ... the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ” with ... at 1:00 pm ET. This conference discusses strategies to prevent readmissions in light ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... squash, announced it has enlisted New York City-based sports and entertainment marketing firm ... and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes first-time ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, ... Spice", it has been used for thousands of years. , "The West has caught ... of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy of ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based ... into the challenges employers face in trying to balance both short-term and long-term ... programs? Adding to the growing complexity, companies are finding that the short-term ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... Device Library for documenting and diagramming network and data center assets and audio-video ... NetZoom subscribers can request new equipment shapes for free and download shapes and ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... at Proton Therapy Centers & Forecast" report to their offering. ... Proton Therapy Market in ... its market value in 2016. There are currently three proton therapy centers ... to treat more patients. In Italy , the first ...
(Date:3/29/2017)... 2017  Providence Medical Technology, Inc., an innovator ... two industry veterans to the commercial leadership team.  ... to lead Global Marketing, and Michael Scott ... and Mr. Scott have over 40 years of ... joins the company with over 22 years of ...
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
Breaking Medicine Technology: